bmt {mstate}R Documentation

BMT data from Klein and Moeschberger

Description

A data frame of 137 rows (patients) and 22 columns. The included variables are

group
Disease group; 1 = ALL, 2 = AML Low Risk, 3 = AML High Risk
t1
Time in days to death or last follow-up
t2
Disease-free survival time in days (time to relapse, death or last follow-up)
d1
Death indicator; 1 = dead, 0 = alive
d2
Relapse indicator; 1 = relapsed, 0 = disease-free
d3
Disease-free survival indicator; 1 = dead or relapsed, 0 = alive and disease-free)
ta
Time in days to Acute Graft-versus-Host Disease (AGVHD)
da
Acute GVHD indicator; 1 = Acute GVHD, 0 = No Acute GVHD
tc
Time (days) to Chronic Graft-vrsus-Host Disease (CGVHD)
dc
Chronic GVHD indicator; 1 = Chronic GVHD, 0 = No Chronic GVHD
tp
Time (days) to platelet recovery
dp
Platelet recovery indicator; 1 = platelets returned to normal, 0 = platelets never returned to normal
z1
Patient age in years
z2
Donor age in years
z3
Patient sex; 1 = male, 0 = female
z4
Donor sex; 1 = male, 0 = female
z5
Patient CMV status; 1 = CMV positive, 0 = CMV negative
z6
Donor CMV status; 1 = CMV positive, 0 = CMV negative
z7
Waiting time to transplant in days
z8
FAB; 1 = FAB grade 4 or 5 and AML, 0 = Otherwise
z9
Hospital; 1 = The Ohio State University, 2 = Alferd , 3 = St. Vincent, 4 = Hahnemann
z10
MTX used as a Graft-versus-Host prophylactic; 1 = yes, 0 = no

Usage

data(bmt)

Format

A data frame, see data.frame.

References

Klein and Moeschberger (1997). Survival Analysis Techniques for Censored and Truncated Data, Springer, New York.


[Package mstate version 0.2.3 Index]